focus -WSS

focus

author：hotspot 2025-10-01 23:31:33 - browse：91118

green electrocardiogram scan. -- health tech coverage from STAT — Adobe

As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected.

The algorithm, which is part of software developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration. The tool, called Viz HCM, looks at 12-lead electrocardiograms collected during routine care and flags suspected cases of hypertrophic cardiomyopathy, or HCM, for further evaluation. As part of a multi-year agreement between the companies, BMS — whose drug, Camzyos, is used to treat HCM — provided funding and scientific input for the development of the algorithm.

“BMS has a vested interest in finding more patients with HCM,” said Matthew Martinez, a cardiologist who leads Viz.ai’s HCM medical advisory board. “Why? Because they’re so philanthropic? No, they want to sell more drugs. They want to help more people by identifying more people.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： EMA weighs against approval for Mirati's lung cancer drug

leisure time

WSS

Scientists unlock the key to scar

How Brent Saunders' Allergan experiment failed

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

New chart reveals military’s vast involvement in Operation Warp Speed

House looks to weaken Medicare negotiation

Wikipedia

focus

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Affirmative action in medical school literally saved lives

Medical device lobby: We're tired of waiting on Medicare coverage

Dobbs anniversary: the lost opportunity of abortion as health care

FogPharma raises $145 million in rare Series E round

Hollywood unions extend contract negotiations for actors

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Alkermes shareholders re

EMA weighs against approval for Mirati's lung cancer drug

focus

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

House looks to weaken Medicare negotiation

Trump Organization, Michael Cohen agree to settle million

Covid isolation guidance eased by the CDC

AstraZeneca loses challenge to Medicare drug price negotiation

Flu vaccine offering decent levels of protection this winter, new data show

knowledge

hotspot

leisure time

hotspot